Overview A Dose-ranging Study to Evaluate Efficacy and Safety of VX-150 in Subjects With Acute Pain Following Bunionectomy Status: Completed Trial end date: 2019-01-25 Target enrollment: Participant gender: Summary This study will evaluate the dose-response relationship and safety of VX-150 in treating acute pain following bunionectomy. Phase: Phase 2 Details Lead Sponsor: Vertex Pharmaceuticals Incorporated